ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,487.03
0.00%
US Tech 100
19,475.60
0.35%
Dow Jones
38,834.86
0.00%
Brent Oil
85.115
0.50%
Bitcoin
65,733.71
1.18%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Extendicare Inc (EXE) Quote

Extendicare Inc

Extendicare Inc (EXE)

Exel Industries
7.38
0.00
(0.00%)
Closed June 20 4:12PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
7.38
Bid
7.30
Ask
7.30
Volume
-
0.00 Day's Range 0.00
5.75 52 Week Range 8.03
Market Cap
86.922M
Previous Close
7.38
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
135,629
Shares Outstanding
11,778,000
Dividend Yield
-
PE Ratio
2.56
Earnings Per Share (EPS)
2.89
Revenue
1.3B
Net Profit
33.98M

About Extendicare Inc

Sector
Nursng,personal Care Fac,nec
Industry
Real Estate Investment Trust
Website
www.extendicare.com
Headquarters
Markham, Ontario, Can
Founded
1993
Extendicare Inc is listed in the Nursng,personal Care Fac sector of the Toronto Stock Exchange with ticker EXE. The last closing price for Extendicare was $7.38. Over the last year, Extendicare shares have traded in a share price range of $ 5.75 to $ 8.03.

Extendicare currently has 11,778,000 shares outstanding. The market capitalization of Extendicare is $86.92 million. Extendicare has a price to earnings ratio (PE ratio) of 2.56.

EXE Latest News

More News

Extendicare Announces June 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

June 17 2024
GlobeNewswire Inc.

Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders

MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of...

May 23 2024
GlobeNewswire Inc.

Extendicare Announces 2024 First Quarter Results

MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are...

May 15 2024
GlobeNewswire Inc.

Extendicare Announces April 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

April 15 2024
GlobeNewswire Inc.

Extendicare Announces Timing of 2024 First Quarter Results and Conference Call

MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first...

April 04 2024
GlobeNewswire Inc.

Extendicare Announces 2023 Fourth Quarter and Year End Results

MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023...

March 07 2024
GlobeNewswire Inc.

Extendicare ouvre les marchés

Extendicare ouvre les marchés Canada NewsWire TORONTO, le 15 févr. 2024 TORONTO, le 15 févr. 2024 /CNW/ - Le Dr Michael Guerriere, président et chef de la direction, Extendicare Inc. («...

February 15 2024
PR Newswire (Canada)

Extendicare Opens the Market

Extendicare Opens the Market PR Newswire TORONTO, Feb. 15, 2024 TORONTO, Feb. 15, 2024 /PRNewswire/ - Dr. Michael Guerriere, President and Chief Executive Officer, Extendicare Inc...

February 15 2024
PR Newswire (US)

Extendicare Announces February 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

February 15 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-1.67.57.637.29857887.42055751CS
4-0.51-6.4638783277.897.897.22915867.44116403CS
12-0.34-4.404145077727.728.037.21356297.51087874CS
260.131.793103448287.258.036.631275297.35232246CS
520.172.357836338427.218.035.751306116.99313779CS
156-0.98-11.72248803838.368.715.751591937.1525734CS
260-1.03-12.24732461368.419.64.92143136.90497485CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
$ 1.07
(133.42%)
14.81M
GRDIGRIID Infrastructure Inc
$ 1.1302
(101.82%)
28.37M
BRHYBlackRock High Yield ETF
$ 80.05
(58.99%)
7
SMXSMX Security Matters Public Company
$ 0.1687
(41.76%)
78.65M
ZAPPZapp Electric Vehicles Group Ltd
$ 1.84
(35.29%)
1.54M
MBIOMustang Bio Inc
$ 0.50
(-41.18%)
9.1M
NLSPNLS Pharmaceutics Ltd
$ 0.202
(-25.21%)
2.71M
KAVLKaival Brands Innovations Group Inc
$ 3.37
(-25.11%)
42.63k
SONNSonnet BioTherapeutics Holdings Inc
$ 1.16
(-24.18%)
16.59k
ASNSActelis Networks Inc
$ 1.71
(-19.34%)
513.7k
SMXSMX Security Matters Public Company
$ 0.1695
(42.44%)
78.75M
SLNASelina Hospitality PLC
$ 0.068
(-2.44%)
36.36M
GRDIGRIID Infrastructure Inc
$ 1.11
(98.21%)
28.47M
PRSTPresto Technologies Inc
$ 0.0934
(26.90%)
26.25M
VERBVerb Technology Company Inc
$ 0.1415
(19.41%)
24.6M

EXE Discussion

View Posts
MisterEC MisterEC 8 years ago
I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
(very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
at these prices, but management wants to expand the business. That would be poor capital allocation.
James Royal
(TMFRoyal)
Jan 23, 2015 at 10:06AM
👍️0
clotter2 clotter2 9 years ago
Extendicare breaking resistance level. This should get good from here . LONG+
👍️0
clotter2 clotter2 9 years ago
I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...
👍️0
toddski toddski 9 years ago
Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/
👍️0
toddski toddski 9 years ago
Extendicare announced 10% share buyback program:

http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html
👍️0

Your Recent History

TSX
EXE
Extendicare
NYSE
AMZY
Tidal ETF Trust
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved